BioCentury
ARTICLE | Company News

Management tracks: Inovio, Sangamo, Innate

March 12, 2019 10:29 PM UTC

Inovio CMO Mark Bagarazzi has left the company. Inovio Pharmaceuticals Inc. (NASDAQ:INO) said a newly formed medical council -- VPs of Clinical Development Prakash Bhuyan, Jeffrey Skolnik and Scott White -- will now oversee the cancer and infectious disease company's clinical activities.

The company also hired Jacqueline Shea as EVP and COO, succeeding Niranjan Sardesai. Sardesai is now CEO of Geneos Therapeutics Inc. (Plymouth Meeting, Pa.), an Inovio spinout that he co-founded last month to develop personalized cancer treatments. Upon its formation, Geneos raised the first close of a tranched $10.5 million series A round led by Santé Ventures. Shea was CEO and COO of Aeras Global TB Vaccine Foundation (Rockville, Md.)...